Thursday, 5 December 2024 | 14:30 - 14:50
TregTacRes Trial - An open-label, active-controlled single ascending dose, first-in-human study to investigate the safety and tolerability of TregTacRes as an adjunctive therapy in living-donor kidney recipients
Format:In-person
- In vivo engraftment (part 1)